on Bausch Health Companies Inc. (NASDAQ:BHC)
Bausch Health to Slash Debt by $900 Million
Bausch Health Companies Inc. announced plans to reduce its debt by approximately $900 million. The initiative involves redeeming $602 million of Bausch Health Americas' Senior Notes due 2026. The redemption is set for August 28, 2025, using cash reserves.
The company also plans to repay $300 million under its Receivables Facility by October 27, 2025. This aligns with Bausch Health's strategy to optimize its capital structure. Bausch Health, a diversified pharmaceutical entity, has its primary focus on pharmaceuticals in various healthcare segments.
The redemption process will be managed through the Depository Trust Company's procedures, with The Bank of New York Mellon acting as the U.S. paying agent.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Bausch Health Companies Inc. news